
TB medicine deal offers short-term solution, but J&J needs to do more for all affected countries
Christophe Perrin, TB advocacy pharmacist, MSF Access Campaign “Today’s announcement by the Stop TB Partnership/Global Drug Facility about a deal with pharmaceutical corporation Johnson & Johnson (J&J), for access to affordable generic versions of the lifesaving